Drugs / Granulocyte Macrophage Colony Stimulation Factor
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT04408092 | Jun 2013 → Sep 2021 | childhood ependymoma | University of Colorado, Denver | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Granulocyte Macrophage Colony Stimulation Factor | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04408092 ↗ |
| Known as | rGM-CSF | “Recombinant Granulocyte Macrophage Colony Stimulation Factor (rGM-CSF) is a hematopoietic growth factor which supports survival, clonal expansion, and differentiation of...” NCT04408092 ↗ |
| Modality | Protein / enzyme biologic | “Recombinant Granulocyte Macrophage Colony Stimulation Factor (rGM-CSF) is a hematopoietic growth factor” NCT04408092 ↗ |